Targeting a powerful immune response in the liver is key.

The last ten years has seen significant advances in the field of immunotherapy and it is now recognised by researchers, clinicians, industry and regulators as an essential modality to treat many diseases. It offers significant advantages over other therapies by reducing side effects, overcoming immune tolerance and offering greater specificity to achieve long lasting results for patients.